Scienjoy Holding Corp (SJ) reported $177.5M in revenue for fiscal year 2025, down 4.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Scienjoy is harvesting working capital into cash while reported earnings absorb a much larger hit.
Positive cash flow in FY2025 did not come from profitability: operating cash flow held at$10.1M even as net income fell to-$84.0M . The cleaner explanation is working-capital release, because accounts receivable collapsed to$6.2M from$31.0M as revenue kept contracting.
Gross margin recovered to
Liquidity is unusually strong for a loss-making year: cash of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Scienjoy Holding Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Scienjoy Holding Corp has an operating margin of -6.3%, meaning the company loses $6 on every $100 of revenue. This results in a profitability score of 25/100. This is down from 3.0% the prior year.
Scienjoy Holding Corp's revenue declined 4.9% year-over-year, from $186.8M to $177.5M. This contraction results in a growth score of 14/100.
Scienjoy Holding Corp carries a low D/E ratio of 0.19, meaning only $0.19 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 75/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.60, Scienjoy Holding Corp holds $3.60 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 83/100.
Scienjoy Holding Corp has a free cash flow margin of 5.6%, earning a moderate score of 51/100. The company generates positive cash flow after capital investments, but with room for improvement.
Scienjoy Holding Corp posts a -95.4% return on equity (ROE), meaning it loses $95 for every $100 of shareholders' equity. This results in a returns score of 23/100. This is down from 3.3% the prior year.
Scienjoy Holding Corp scores 3.46, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Scienjoy Holding Corp passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.
Scienjoy Holding Corp reported a net loss of $84.0M while generating $10.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Scienjoy Holding Corp generated $177.5M in revenue in fiscal year 2025. This represents a decrease of 4.9% from the prior year.
Scienjoy Holding Corp's EBITDA was -$10.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 252.3% from the prior year.
Scienjoy Holding Corp reported -$84.0M in net income in fiscal year 2025. This represents a decrease of 1643.8% from the prior year.
Scienjoy Holding Corp earned -$2.01 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1646.2% from the prior year.
Cash & Balance Sheet
Scienjoy Holding Corp generated $10.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 7.4% from the prior year.
Scienjoy Holding Corp held $44.0M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Scienjoy Holding Corp's gross margin was 18.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the prior year.
Scienjoy Holding Corp's operating margin was -6.3% in fiscal year 2025, reflecting core business profitability. This is down 9.3 percentage points from the prior year.
Scienjoy Holding Corp's net profit margin was -47.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 50.2 percentage points from the prior year.
Scienjoy Holding Corp's ROE was -95.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 98.7 percentage points from the prior year.
Capital Allocation
Scienjoy Holding Corp invested $11.9M in research and development in fiscal year 2025. This represents a decrease of 3.7% from the prior year.
Scienjoy Holding Corp invested $120K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 11.1% from the prior year.
Not reported for fiscal year 2025.
SJ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $177.5M-4.9% | $186.8M-9.5% | $206.3M-27.1% | $283.2M+8.1% | $262.0M+39.9% | $187.3M | N/A | N/A |
| Cost of Revenue | $145.1M-5.3% | $153.2M-14.5% | $179.2M-26.0% | $242.1M+13.1% | $214.2M+45.6% | $147.1M | N/A | N/A |
| Gross Profit | $32.5M-3.4% | $33.6M+23.9% | $27.1M-33.9% | $41.1M-14.1% | $47.8M+18.9% | $40.2M | N/A | N/A |
| R&D Expenses | $11.9M-3.7% | $12.4M+17.1% | $10.6M+8.0% | $9.8M-10.9% | $11.0M+125.7% | $4.9M | N/A | N/A |
| SG&A Expenses | $12.7M+21.2% | $10.5M-1.4% | $10.6M+20.4% | $8.8M-13.6% | $10.2M+97.1% | $5.2M | N/A | N/A |
| Operating Income | -$11.3M-302.1% | $5.6M+73.8% | $3.2M | N/A | N/A | N/A | -$937K | N/A |
| Income Tax | -$11.5M-765.9% | $1.7M+44.6% | $1.2M-54.4% | $2.6M+198.0% | $879K-22.6% | $1.1M | N/A | N/A |
| Net Income | -$84.0M-1643.8% | $5.4M+225.4% | -$4.3M-115.5% | $28.0M+5.1% | $26.7M-1.1% | $27.0M+17726.5% | $151K | N/A |
| EPS (Diluted) | -$2.01-1646.2% | $0.13+218.2% | -$0.11-115.5% | $0.71-18.4% | $0.87 | $1.01 | N/A | N/A |
Not reported in any period shown, so not listed: Interest Expense.
SJ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $101.6M-47.2% | $192.5M-5.6% | $204.0M-6.3% | $217.8M+27.4% | $170.9M+37.4% | $124.4M+112.3% | $58.6M+15863.9% | $367K |
| Current Assets | $54.8M-26.6% | $74.6M-8.2% | $81.3M-13.6% | $94.1M-8.1% | $102.4M+43.1% | $71.5M+574769.4% | $12K-76.5% | $53K |
| Cash & Equivalents | $44.0M+27.2% | $34.6M+19.6% | $28.9M+13.9% | $25.4M-32.8% | $37.8M+9.8% | $34.4M+63.6% | $21.1M+39664.2% | $53K |
| Accounts Receivable | $6.2M-80.0% | $31.0M-15.7% | $36.8M-19.9% | $45.9M+41.8% | $32.4M-7.4% | $35.0M | N/A | N/A |
| Goodwill | N/A | $25.0M-2.6% | $25.7M+2.6% | $25.1M+73.4% | $14.4M+2.4% | $14.1M | N/A | N/A |
| Total Liabilities | $16.7M-44.5% | $30.1M-28.4% | $42.1M-14.5% | $49.2M+12.1% | $43.9M-18.6% | $54.0M+0.7% | $53.6M+13206.3% | $403K |
| Current Liabilities | $15.2M-30.8% | $22.0M-33.2% | $33.0M-14.4% | $38.5M+10.9% | $34.7M-18.4% | $42.5M+19062.8% | $222K-44.9% | $403K |
| Long-Term Debt | N/A | N/A | $2.3M+4.9% | $2.2M+73.3% | $1.3M | N/A | N/A | N/A |
| Total Equity | $88.0M-46.4% | $164.3M+1.4% | $162.1M-3.7% | $168.3M+32.5% | $127.0M+80.4% | $70.4M+1308.5% | $5.0M+14091.1% | -$36K |
| Retained Earnings | $13.2M-85.5% | $90.8M+2.5% | $88.6M-8.2% | $96.4M+28.2% | $75.2M+52.1% | $49.4M+54498.3% | $91K+248.9% | -$61K |
Not reported in any period shown, so not listed: Inventory.
SJ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.1M+7.1% | $9.4M-34.9% | $14.5M+73.3% | $8.3M-54.3% | $18.3M-23.4% | $23.8M+3428.4% | -$716K | N/A |
| Capital Expenditures | $120K-11.1% | $135K+95.7% | $69K-77.9% | $312K+43.1% | $218K+30.5% | $167K | N/A | N/A |
| Free Cash Flow | $10.0M+7.4% | $9.3M-35.5% | $14.4M+79.2% | $8.0M-55.5% | $18.0M-23.8% | $23.7M | N/A | N/A |
| Investing Cash Flow | -$868K+68.4% | -$2.7M+71.0% | -$9.5M+42.4% | -$16.4M+9.1% | -$18.1M-188.0% | -$6.3M+89.1% | -$57.5M | N/A |
| Financing Cash Flow | -$14K+22.2% | -$18K+97.6% | -$735K+55.9% | -$1.7M-169.4% | $2.4M+167.1% | -$3.6M-106.1% | $58.2M | N/A |
| Share Buybacks | N/A | $101K-73.8% | $385K-83.9% | $2.4M | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
SJ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.3%+0.3pp | 18.0%+4.8pp | 13.2%-1.3pp | 14.5%-3.7pp | 18.2%-3.2pp | 21.5% | N/A | N/A |
| Operating Margin | -6.3%-9.3pp | 3.0%+1.4pp | 1.6% | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -47.3%-50.2pp | 2.9%+5.0pp | -2.1%-12.0pp | 9.9%-0.3pp | 10.2%-4.2pp | 14.4% | N/A | N/A |
| Return on Equity | -95.4%-98.7pp | 3.3%+6.0pp | -2.7%-19.3pp | 16.7%-4.3pp | 21.0%-17.3pp | 38.3%+35.3pp | 3.0% | N/A |
| Return on Assets | -82.6%-85.5pp | 2.8%+5.0pp | -2.1%-15.0pp | 12.9%-2.7pp | 15.6%-6.1pp | 21.7%+21.4pp | 0.3% | N/A |
| Current Ratio | 3.60+0.2x | 3.39+0.9x | 2.460.0x | 2.44-0.5x | 2.95+1.3x | 1.68+1.6x | 0.06-0.1x | 0.13 |
| Debt-to-Equity | 0.190.0x | 0.18+0.2x | 0.010.0x | 0.010.0x | 0.01-0.8x | 0.77-10.0x | 10.72 | N/A |
| FCF Margin | 5.6%+0.6pp | 5.0%-2.0pp | 7.0%+4.1pp | 2.8%-4.0pp | 6.9%-5.8pp | 12.6% | N/A | N/A |
Similar Companies
Where Scienjoy Holding Corp Ranks
Frequently Asked Questions
What is Scienjoy Holding Corp's annual revenue?
Scienjoy Holding Corp (SJ) reported $177.5M in total revenue for fiscal year 2025. This represents a -4.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Scienjoy Holding Corp's revenue growing?
Scienjoy Holding Corp (SJ) revenue declined by 4.9% year-over-year, from $186.8M to $177.5M in fiscal year 2025.
Is Scienjoy Holding Corp profitable?
No, Scienjoy Holding Corp (SJ) reported a net income of -$84.0M in fiscal year 2025, with a net profit margin of -47.3%.
What is Scienjoy Holding Corp's EBITDA?
Scienjoy Holding Corp (SJ) had EBITDA of -$10.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Scienjoy Holding Corp's gross margin?
Scienjoy Holding Corp (SJ) had a gross margin of 18.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Scienjoy Holding Corp's operating margin?
Scienjoy Holding Corp (SJ) had an operating margin of -6.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Scienjoy Holding Corp's net profit margin?
Scienjoy Holding Corp (SJ) had a net profit margin of -47.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Scienjoy Holding Corp's return on equity (ROE)?
Scienjoy Holding Corp (SJ) has a return on equity of -95.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Scienjoy Holding Corp's free cash flow?
Scienjoy Holding Corp (SJ) generated $10.0M in free cash flow during fiscal year 2025. This represents a 7.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Scienjoy Holding Corp's operating cash flow?
Scienjoy Holding Corp (SJ) generated $10.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Scienjoy Holding Corp's total assets?
Scienjoy Holding Corp (SJ) had $101.6M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Scienjoy Holding Corp's capital expenditures?
Scienjoy Holding Corp (SJ) invested $120K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Scienjoy Holding Corp spend on research and development?
Scienjoy Holding Corp (SJ) invested $11.9M in research and development during fiscal year 2025.
What is Scienjoy Holding Corp's current ratio?
Scienjoy Holding Corp (SJ) had a current ratio of 3.60 as of fiscal year 2025, which is generally considered healthy.
What is Scienjoy Holding Corp's debt-to-equity ratio?
Scienjoy Holding Corp (SJ) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Scienjoy Holding Corp's return on assets (ROA)?
Scienjoy Holding Corp (SJ) had a return on assets of -82.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Scienjoy Holding Corp's Altman Z-Score?
Scienjoy Holding Corp (SJ) has an Altman Z-Score of 3.46, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Scienjoy Holding Corp's Piotroski F-Score?
Scienjoy Holding Corp (SJ) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Scienjoy Holding Corp's earnings high quality?
Scienjoy Holding Corp (SJ) reported a net loss of $84.0M while generating $10.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Scienjoy Holding Corp?
Scienjoy Holding Corp (SJ) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.